MKTX vs STEP

MKTX exhibits a stable financial foundation with a Piotroski F-Score of 4/9 and a very strong balance sheet characterized by low leverage (Debt/Equity 0.25). While the current price of $174.56 sits below the growth-based intrinsic value of $196.18, it remains significantly elevated compared to the defensive Graham Number of $69.22. The company shows impressive earnings growth (45.3% YoY), yet this is decoupled from stagnant revenue growth (3.5%), suggesting efficiency gains rather than market expansion. A severely bearish technical trend (0/100) and poor long-term price performance (-65.4% over 5 years) offset the positive analyst consensus.

StepStone Group presents a stark contrast between explosive growth and deteriorating fundamental health, evidenced by a weak Piotroski F-Score of 3/9. While revenue growth is exceptional at 73% YoY and analysts maintain a strong buy rating, the company suffers from negative profit margins, negative ROE, and a current ratio below 1.0. The dividend is currently unsustainable with a payout ratio of 167.21%, and heavy insider selling by the CEO and COO suggests a lack of confidence at current valuation levels. The stock is essentially a high-growth play with significant balance sheet risks.